Literature DB >> 11872055

Estimation of prognosis after hepatectomy for hepatocellular carcinoma.

W-C Lee1, L-B Jeng, M-F Chen.   

Abstract

BACKGROUND: The preferred means of treatment for hepatocellular carcinoma is surgical resection. However, the tumour recurrence rate is high. Accurate estimation of the risk of tumour recurrence after hepatectomy may facilitate the administration of adjuvant therapy after hepatectomy to patients with a high likelihood of tumour recurrence.
METHODS: The clinical and pathological profiles of 176 patients undergoing hepatectomy for hepatocellular carcinoma from March 1992 to August 1998 were reviewed. The Kaplan--Meier method and log rank test were used to analyse univariate prognostic factors. The Cox proportional hazard model was used for multivariate analysis. Disease-free and overall cumulative survival rates were estimated with respect to the number of prognostic factors.
RESULTS: Independent factors associated with a lower disease-free survival included the presence of venous infiltration, presence of daughter tumours, absence of tumour encapsulation and tumour size exceeding 5 cm. Factors decreasing the overall survival rate included the presence of venous infiltration, absence of tumour encapsulation and surgical resection margin less than 1 cm. The 1-year disease-free survival rate decreased from 77.5(s.e. 5.6) to 14.0(8.5) per cent when the number of risk factors present increased from zero to three. The 5-year survival rate decreased from 60.2(11.7) per cent to zero when the number of risk factors increased from zero to three.
CONCLUSION: The deterioration of disease-free or overall survival of patients with hepatocellular carcinoma after hepatectomy correlates with increasing number of risk factors. The number of risk factors can be employed to accurately estimate disease-free and overall survival.

Entities:  

Mesh:

Year:  2002        PMID: 11872055     DOI: 10.1046/j.0007-1323.2001.02034.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  23 in total

1.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Tumor vaccine against recurrence of hepatocellular carcinoma.

Authors:  Bao-Gang Peng; Li-Jiang Liang; Qiang He; Ming Kuang; Jia-Ming Lia; Ming-De Lu; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

3.  Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis.

Authors:  Dean J Arnaoutakis; Michael N Mavros; Feng Shen; Sorin Alexandrescu; Amin Firoozmand; Irinel Popescu; Matthew Weiss; Christopher L Wolfgang; Michael A Choti; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2014-01       Impact factor: 5.344

4.  Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma.

Authors:  Yuichi Sugino; Koichiro Yamakado; Takashi Yamanaka; Masashi Fujimori; Atsuhiro Nakatsuka; Haruyuki Takaki; Yoshiyuki Takei; Hajime Sakuma; Shuji Isaji
Journal:  Jpn J Radiol       Date:  2017-03-29       Impact factor: 2.374

5.  Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer: a prospective study.

Authors:  E Berber; S Rogers; A Siperstein
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

6.  Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.

Authors:  Zheng-Gang Ren; Zhi-Ying Lin; Jing-Lin Xia; Sheng-Long Ye; Zeng-Chen Ma; Qing-Hai Ye; Lun-Xiu Qin; Zhi-Quan Wu; Jia Fan; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

7.  Prognostic impact of Fas ligand on hepatocellular carcinoma after hepatectomy.

Authors:  Wei-Chen Lee; Ming-Chin Yu; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

8.  Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors.

Authors:  Sicong Ma; Min Ding; Jiang Li; Tao Wang; Xingxing Qi; Yaoping Shi; Yanan Ming; Jiachang Chi; Zhi Wang; Xiaoyin Tang; Dan Cui; Yuan Zhang; Bo Zhai
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-20       Impact factor: 4.553

9.  Inhibitory effect of dimeric beta peptide on the recurrence and metastasis of hepatocellular carcinoma in vitro and in mice.

Authors:  Song-Mei Wang; Jun Zhu; Luan-Feng Pan; Yin-Kun Liu
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

10.  Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.

Authors:  Theodoros Michelakos; Filippos Kontos; Yurie Sekigami; Motaz Qadan; Lei Cai; Onofrio Catalano; Vikram Deshpande; Madhukar S Patel; Teppei Yamada; Nahel Elias; Leigh Anne Dageforde; Shoko Kimura; Tatsuo Kawai; Kenneth K Tanabe; James F Markmann; Heidi Yeh; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2020-08-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.